natgillin/translations-raw huggingface dataset:
Patient mobility with prior authorisation 
Mobilnost pacientov s predhodno odobritvijo
][8: Article 4(2)(c), (e)-(f), 4(3), 4(4), 5(b)-(d), 7(1), 9(4)-(5). 
][8: Člen 4(2)(c), (e) in (f), člen 4(3), člen 4(4), člen 5(b), (c) in (d), člen 7(1), člen 9(4) in (5).
For the years 2015 and 2017, when France was not able to provide data on patient mobility with PA, Luxembourg to Germany and Ireland to UK were amongst the most common cases of patient mobility. 
V letih 2015 in 2017, ko Francija ni mogla predložiti podatkov o mobilnosti pacientov s predhodno odobritvijo, so bili najpogostejši primeri mobilnosti pacientov mobilnost iz Luksemburga v Nemčijo in iz Irske v Združeno kraljestvo.
The flow maps, as well as the raw data, show clearly that most patients travel from France to other countries, with patient mobility from France to Spain and France to Germany being the most prevalent. 
Diagrami pretoka tako kot neobdelani podatki jasno kažejo, da največ pacientov potuje iz Francije v druge države, pri čemer prevladuje mobilnost pacientov iz Francije v Španijo in iz Francije v Nemčijo.
Patient mobility not subject to prior authorisation 
Mobilnost pacientov, za katero se ne zahteva predhodna odobritev
The aggregated data reported by Member States on the number of requests for PA in 2015, 2016 and 2017 show that such requests remain generally low. 
Zbirni podatki, ki so jih države članice sporočile o številu zahtevkov za predhodno odobritev v letih 2015, 2016 in 2017, kažejo, da jih je na splošno še vedno malo.
[28: IF SBH (International Federation for Spina Bifida and Hydrocephalus) and EDF (European Disability Forum), "Impact of Cross-border Healthcare on Persons with Disabilities and Chronic Conditions", 2017 ][29: https://ec.europa.eu/health/sites/health/files/cross_border_care/docs/2015_operation_report_dir201124eu_en.pdf] 
[28: IF SBH (Mednarodna zveza za spino bifido in hidrocefalijo) in EDF (Evropski invalidski forum), „Impact of Cross-border Healthcare on Persons with Disabilities and Chronic Conditions" (Učinek čezmejnega zdravstvenega varstva na invalide in osebe s kroničnimi obolenji), 2017.
[27: https://ec.europa.eu/health/cross_border_care/key_documents_en] 
[27: https://ec.europa.eu/health/cross_border_care/key_documents_sl.]
Regarding the voluntary cooperation structure (eHealth, HTA, ERNs), the Directive provides the basis for the Commission and Member States to enhance cross-border cooperation and on how broader technological and societal challenges might be met. A number of developments regarding these new perspectives are already underway. 
Kar zadeva strukturo prostovoljnega sodelovanja (e-zdravje, ocenjevanje zdravstvene tehnologije, evropske referenčne mreže), je Direktiva podlaga, na kateri Komisija in države članice krepijo čezmejno sodelovanje in morebitne načine spopadanja s širšimi tehnološkimi in družbenimi izzivi.
Compliance check 
Preverjanje skladnosti
[1: Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients' rights in cross-border healthcare (OJ L 88, 4.4.2011, p. 
[1: Direktiva 2011/24/EU Evropskega parlamenta in Sveta z dne 9. marca 2011 o uveljavljanju pravic pacientov pri čezmejnem zdravstvenem varstvu (UL L 88, 4.4.2011, str.
Financial Implications of Patient Mobility 
Finančne posledice mobilnosti pacientov
[32: https://ec.europa.eu/health/sites/health/files/technology_assessment/docs/2018_mapping_npc_en.pdf][33: Mapping of HTA national organisations programmes and processes in EU and Norway, 2017, Contract nr. 17010402/2016/734820, ISBN: 978-92-79-77080-7] 
][33: Vzporejanje nacionalnih organizacij, programov in postopkov za ocenjevanje zdravstvene tehnologije v EU in na Norveškem, 2017, pogodba št. 17010402/2016/734820, ISBN: 978-92-79-77080-7.]
][31: https://ec.europa.eu/health/cross_border_care/events/ev_20161024_en] 
][31: https://ec.europa.eu/health/cross_border_care/events/ev_20161024_sl.]
[34: https://ec.europa.eu/health/technology_assessment/policy/network_en][35: Commission Implementing Decision 2013/329/EU of 26 June 2013 providing the rules for the establishment,management and transparent functioning of the network of national authorities or bodies responsible for healthtechnology assessment (OJ L 175, 27.6.2013, p. 
][35: Izvedbeni sklep Komisije 2013/329/EU z dne 26. junija 2013 o pravilih za vzpostavitev,upravljanje in pregledno delovanje mreže nacionalnih organov ali teles, pristojnih za ocenjevanjezdravstvene tehnologije (UL L 175, 27.6.2013, str.
[47: Article 10(3) of the Directive. 
[47: Člen 10(3) Direktive.
[41: Regulation (EU) No 1316/2013 of the European Parliament and of the Council of 11 December 2013 establishing the Connecting Europe Facility, amending Regulation (EU) No 913/2010 and repealing Regulations (EC) No 680/2007 and (EC) No 67/2010, OJ L 348, 20.12.2013, p. 
[41: Uredba (EU) št. 1316/2013 Evropskega parlamenta in Sveta z dne 11. decembra 2013 o vzpostavitvi Instrumenta za povezovanje Evrope, spremembi Uredbe (EU) št. 913/2010 in razveljavitvi uredb (ES) št. 680/2007 in (ES) št. 67/2010 (UL L 348, 20.12.2013, str.
][9: Article 4(2)(d).] 
][9: Člen 4(2)(d).]
Completeness check 
Preverjanje popolnosti
][2: Regulations (EC) No 883/2004 of the European Parliament and of the Council of 29 April 2004 on the coordination of social security systems (OJ L 166, 30.4.2004, p. 1) and 987/2009 laying down the procedure for implementing Regulation (EC) No 883/2004 (OJ L 284, 30.10.2009, p.1).] 
][2: Uredba (ES) št. 883/2004 Evropskega parlamenta in Sveta z dne 29. aprila 2004 o koordinaciji sistemov socialne varnosti (UL L 166, 30.4.2004, str. 1) in Uredba (ES) št. 987/2009 o določitvi podrobnih pravil za izvajanje Uredbe (ES) št. 883/2004 (UL L 284, 30.10.2009, str.
In 2017 a total of 74,589 enquiries were received across 22 Member States and Norway, reflecting a very similar use of NCPs to that reported for 2016 when a total of 69,723 enquires were counted across 28 Member States and Norway and in 2015 when a total of 59,558 requests were received in 19 Member States. 
Leta 2017 je bilo v 22 državah članicah in na Norveškem prejetih skupno 74 589 poizvedb, kar kaže na zelo podobno uporabo nacionalnih kontaktnih točk, kot je bila sporočena za leto 2016, ko je bilo v 28 državah članicah in na Norveškem skupno podanih 69 723 poizvedb, ter za leto 2015, ko je bilo v 19 državah članicah prejetih 59 558 zahtevkov.
[49: "Study on Cross-Border Cooperation: Capitalising on existing initiatives for cooperation in cross-border regions", Gesundheit Österreich Forschungs und Planungs GmbH, SOGETI, Maastricht University, 2017][50: See the General Secretariat of the Benelux Union studies, e.g. "Barriers and Opportunities in the Benelux", February 2018.] 
[49: „Study on Cross-Border Cooperation: Capitalising on existing initiatives for cooperation in cross-border regions" (Študija o čezmejnem sodelovanju: izkoriščanje obstoječih pobud za sodelovanje v čezmejnih regijah), Gesundheit Österreich Forschungs und Planungs GmbH, SOGETI, Univerza v Maastrichtu, 2017.
[52: Article 12(5), read together with Article 12(4)(a). 
[52: Člen 12(5) v povezavi s členom 12(4)(a).
[11: Recital 38 of the Directive.] 
[11: Uvodna izjava 38 Direktive.]
Two significant trends emerge from the data on the direction of patient flows, whether it is mobility with or without PA. 
Iz podatkov o cilju pretoka pacientov, in to ne glede na to, ali gre za mobilnost s predhodno odobritvijo ali brez nje, izhajata dva pomembna trenda.
Firstly, the HTA Network which connects national authorities or bodies responsible for HTA. 
Prvi je mreža za ocenjevanje zdravstvenih tehnologij, ki povezuje nacionalne organe ali telesa, pristojne za ocenjevanje zdravstvene tehnologije.
[3: Commission Report on the operation of Directive 2011/24/EU on the application of patients' rights in cross-border healthcare, COM(2015) 421 final, 04.09.2015.] 
[3: Poročilo Komisije o izvajanju Direktive 2011/24/EU o uveljavljanju pravic pacientov pri čezmejnem zdravstvenem varstvu (COM(2015) 421 final z dne 4. septembra 2015).]
Flow Map 2 in Annex B represents the aggregated flows across 2015, 2016 and 2017 for treatment without prior authorisation. 
V diagramu pretoka 2 v Prilogi B so prikazani zbirni pretoki v letih 2015, 2016 in 2017 v zvezi z zdravljenjem brez predhodne odobritve.
It requires the Commission to prepare a report in respect of the delegated powers. 
Komisija mora v skladu s tem členom pripraviti poročilo o pooblastilu.
In 2015 the total number of requests granted was 180,704 across 19 Member States plus Norway; in 2016 the number of requests granted over 22 Member States amounted to 209,568; and in 2017 the total number of requests granted was 194,292 across 20 Member States. 
Leta 2015 so bili skupno odobreni 180 704 zahtevki v 19 državah članicah in na Norveškem, leta 2016 je bilo odobrenih zahtevkov v 22 državah članicah 209 568, leta 2017 pa v 20 državah članicah 194 292.
Flow Map 1 in Annex B represents the aggregated flows across 2015, 2016 and 2017 for treatment requiring prior authorisation. 
V diagramu pretoka 1 v Prilogi B so prikazani zbirni pretoki v letih 2015, 2016 in 2017 v zvezi z zdravljenjem, za katero se zahteva predhodna odobritev.
][15: See e.g. Case C-205/99 Analir and Others [2001] ECR I 1271, paragraphs 35-38; case C-157/99 Smits and Peerbooms, paragraphs 80- 90. 
][15: Glej na primer zadevo C-205/99, Analir in drugi, Recueil 2001, str. I-1271, točke od 35 do 38; zadevo C-157/99, Smits in Peerbooms, točke od 80 do 90.
First, the Commission has made a legislative proposal on health technology assessment (see Chapter 4.1). 
Komisija je na primer pripravila zakonodajni predlog o ocenjevanju zdravstvene tehnologije (glej poglavje 4.1) ter v sporočilu o digitalni preobrazbi zdravstvenega varstva in oskrbe predlagala nadaljnje ukrepe v zvezi z e-zdravjem (glej poglavje 4.2).
A great majority of the issues of compliance examined with Member States at issue have led to a common agreement. 
Soglasje je bilo doseženo v zvezi z veliko večino vprašanj glede skladnosti, proučenih z zadevnimi državami članicami.
Figure 3: Requests for information made to NCPs 
Slika 3: Zahtevki za informacije, ki so jih prejele nacionalne kontaktne točke
[17: Article 8(1) of the Directive.] 
[17: Člen 8(1) Direktive.]
[14: See e.g. Case C205/99 Analir and Others [2001] ECR I1271, paragraph 38; case C-157/99 Smits and Peerbooms, paragraph 90. 
[14: Glej na primer zadevo C-205/99, Analir in drugi, Recueil 2001, str. I-1271, točka 38; zadevo C-157/99, Smits in Peerbooms, točka 90.
Twenty-one infringement procedures were started for non-communication of national transposal measures. 
Ker države članice niso sporočile nacionalnih ukrepov za prenos, je bilo začetih 21 postopkov za ugotavljanje kršitev.
Three Member States, with varying conditions and extent, use the former lower reimbursement level as the reference point for reimbursement of the costs of cross-border healthcare under the Directive. 
Prejšnjo nižjo stopnjo povračila kot referenčno točko za povračilo stroškov čezmejnega zdravstvenega varstva na podlagi Direktive z različnimi pogoji in v različnem obsegu uporabljajo tri države članice.
[18: Article 7(4) of the Directive.] 
[18: Člen 7(4) Direktive.]
[38: https://ec.europa.eu/health/technology_assessment/eu_cooperation_en][39: Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on health technology assessment and amending Directive 2011/24/EU, COM(2018)51 final, 31.01.2018. https://ec.europa.eu/health/technology_assessment/eu_cooperation_en] 
][39: Predlog uredbe Evropskega parlamenta in Sveta o ocenjevanju zdravstvene tehnologije in spremembi Direktive 2011/24/EU (COM(2018) 51 final z dne 31. januarja 2018).
][7: Article 4(2) (a)-(b), 5(b), 6(3). 
][7: Člen 4(2)(a) in (b), člen 5(b) in člen 6(3).
Data on patient mobility 
Podatki o mobilnosti pacientov
Direction of Patient Mobility 
Cilj mobilnosti pacientov
][42: https://ec.europa.eu/health/sites/health/files/ehealth/docs/ev_20161121_co10_en.pdf][43: https://ec.europa.eu/health//sites/health/files/ehealth/docs/eprescription_guidelines_en.pdf] 
][42: https://ec.europa.eu/health/sites/health/files/ehealth/docs/ev_20161121_co10_en.pdf.
This can lead to certain discrepancies. 
Zaradi tega lahko nastanejo določena razhajanja.
In such cases this report contains the updated information. 
V takih primerih to poročilo vsebuje posodobljene informacije.
Traceability. 
Sledljivost.
In the latter case, an infringement proceeding pursuant to Article 258 TFEU is ongoing. 
V tem zadnjem primeru še poteka postopek za ugotavljanje kršitev v skladu s členom 258 PDEU.
Import and export. 
Uvoz in izvoz.
Some Member States would welcome an exchange of best practices in this respect. 
Nekatere države članice bi pozdravile izmenjavo dobrih praks v zvezi s tem.
Cross-border movement of donors. 
Čezmejno gibanje darovalcev.
According to reports from Member States, no such penalties have so far been imposed. 
Po poročanju držav članic take kazni do zdaj še niso bile uporabljene.
Time off work varies from less than half a day to up to two days. 
Dopust lahko traja od manj kot pol dneva do dveh dni.
Shortages, surpluses and self-sufficiency. 
Pomanjkanje, presežek in samozadostnost.
At the end of 2011, 1363 blood establishments were authorised in the EU. 
Konec leta 2011 je bilo v EU odobrenih 1 363 transfuzijskih ustanov.
Member States can add tests for specific components or epidemiological situations. 
Države članice lahko dodajo teste za specifične komponente ali epidemiološke razmere.
Designation of competent authority or authorities 
Imenovanje pristojnega organa ali organov
Data protection and confidentiality. 
Varstvo podatkov in zaupnost.
In all Member States these tests are performed by authorised laboratories. 
V vseh državah članicah te teste opravljajo pooblaščeni laboratoriji.
Public, national suppliers are predominant in a minority of EU countries. 
Javni, nacionalni dobavitelji prevladujejo v manjšini držav EU.
The gaps and difficulties identified may suggest that a further in-depth evaluation might be useful. 
Ugotovljene vrzeli in težave lahko kažejo, da bi lahko bila koristna nadaljnja podrobnejša ocena.
The Commission will follow-up with Member States to address situations where the legislation might not have been fully or correctly implemented. 
Komisija bo nadalje spremljala države članice, da bi rešila primere, v katerih se zakonodaja morda ne izvaja v celoti ali ustrezno.
Combining the implementation of all three pillars, where possible, is probably the most effective way to minimise risks. 
Združevanje izvajanja vseh treh stebrov, kadar je to mogoče, je verjetno najučinkovitejši način za zmanjšanje tveganj na najnižjo mogočo raven.
No problems were reported regarding the implementation of the provisions related to data protection. 
V zvezi z izvajanjem določb o varstvu podatkov niso bile sporočene nobene težave.
The Commission is required to transmit these national reports to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions. 
Komisija mora ta nacionalna poročila poslati Evropskemu parlamentu, Svetu, Ekonomsko-socialnemu odboru in Odboru regij.
Views vary on whether such cross-border donations are desirable. 
Mnenja o tem, ali so taka čezmejna darovanja zaželena, se razlikujejo.
Significant progress has been made in many areas, often through the active support of Commission funded projects and other initiatives. 
Na številnih področjih je napredek znaten, pogosto zaradi dejavne podpore projektov, ki jih financira Komisija, in drugih pobud.
[7: Links to be added once published] 
[7: Povezave bodo dodane, ko bosta objavljena.]
There are a small number of international companies that supply the majority of countries. 
Majhno število mednarodnih družb dobavlja večini držav.
Several Member States expressed interest in applying instead a risk-based prioritisation planning for inspections. 
Več držav članic je izrazilo zanimanje, da se namesto tega uporabi prednostno načrtovanje inšpekcijskih pregledov na podlagi tveganja.
Some Member States called for more common procedures for authorisation across the Union. 
Nekatere države članice so pozvale k enotnejšim postopkom odobritve po vsej Uniji.
In 2012, 22 countries reported having performed 760 on-site inspections. 
Leta 2012 je 22 držav poročalo, da je bilo opravljenih 760 inšpekcijskih pregledov na kraju samem.
All Member States replied to the transposition questionnaire. 
Vse države članice so odgovorile na vprašalnik o prenosu.
Irrespective of the organisational set-up, it is important that authorities have appropriate resources at their disposal to enable them to carry out the required duties, as well as to ensure their independence from economic operators in the sector and from other influences. 
Ne glede na organizacijsko strukturo je pomembno, da imajo organi na voljo ustrezne vire, ki jim omogočajo opravljanje zahtevanih nalog ter zagotavljajo njihovo neodvisnost od gospodarskih subjektov v sektorju in od drugih vplivov.
Voluntary and unpaid donation (VUD) 
Prostovoljno in brezplačno darovanje (PBD)
One national competent authority has taken the lead on developing such an initiative within the network of national competent authorities. 
Eden od nacionalnih pristojnih organov je prevzel vodilno vlogo pri razvoju take pobude znotraj mreže nacionalnih pristojnih organov.
All Member States have appointed competent authorities for blood. 
Vse države članice so imenovale pristojne organe za kri.
In some Member States, donors receive a fixed payment that is not directly related to actual costs incurred. 
V nekaterih državah članicah darovalci prejmejo fiksno plačilo, ki ni neposredno povezano z dejanskimi stroški.
VUD is a factor which is not only ethical in nature, but which might also contribute to higher safety standards and, therefore, be important for the protection of human health. 
PBD je dejavnik, ki ni zgolj etičen, temveč lahko prispeva tudi k višjim varnostnim standardom ter je zato lahko pomemben za varstvo zdravja ljudi.
These authorisations also cover 731 mobile sites, 534 satellite sites and 253 plasma collection centres. 
Te odobritve vključujejo tudi 731 mobilnih enot, 534 satelitskih enot in 253 centrov za zbiranje krvne plazme.
The Commission will consider the need for an evaluation in order to assess the relevance, effectiveness, efficiency, coherence and the EU added value of Directive 2002/98/EC and its implementing Directives. 
Komisija bo razmislila o potrebi po ocenjevanju za ovrednotenje ustreznosti, učinkovitosti, uspešnosti, skladnosti in dodane vrednosti EU Direktive 2002/98/ES in njenih izvedbenih direktiv.
Inspections and control measures. 
Inšpekcijski pregledi in kontrolni ukrepi.
Fig. 4: Countries reporting regular shortages 
Slika 4: Države, ki poročajo o rednem pomanjkanju
Testing and inactivation technologies. 
Testiranje in tehnologije inaktivacije.
However, some difficulties in interpretation, implementation and enforcement of the legislation were identified, in some cases due to technological and scientific advances since its adoption. 
Vendar je bilo ugotovljenih nekaj težav pri razlagi, izvajanju in izvrševanju zakonodaje, v nekaterih primerih zaradi tehnološkega in znanstvenega napredka od njenega sprejetja.
In almost every country, donation promotion activities are the main actions taken to increase supply. 
V skoraj vseh državah so dejavnosti spodbujanja darovanja glavni ukrepi za povečanje dobave.
Quality and safety of blood and blood components 
Kakovost in varnost krvi in komponent krvi
Less than half of the countries reported having national guiding principles to define what form of compensation or other practice is allowed and under which circumstances. 
Manj kot polovica držav je poročala, da imajo nacionalna vodilna načela za opredelitev, katera oblika nadomestila ali druga praksa je dovoljena in v kakšnih okoliščinah.
This topic is intrinsically linked with the promotion and success of the principle of VUD, as highlighted in recital 23 of Directive 2002/98/EC. 
Ta tema je neločljivo povezana s spodbujanjem in uspehom načela PBD, kot je poudarjeno v uvodni izjavi 23 Direktive 2002/98/ES.
The implementation survey confirmed that this core responsibility of national competent authorities is well developed across the Union. 
Anketa o izvajanju je potrdila, da je ta ključna odgovornost nacionalnih pristojnih organov dobro razvita po vsej Uniji.
There are differences between Member States in relation to the duration and terms of renewal of the individual authorisations. 
Med državami članicami obstajajo razlike glede trajanja in pogojev obnove posameznih odobritev.
The UK and Ireland apply this policy as part of their risk mitigation strategy for transmission of variant Creutzfeldt Jacob disease. 
Združeno kraljestvo in Irska to politiko uporabljata kot del strategije za blažitev tveganj prenosa različice Creutzfeldt-Jacobove bolezni.
In order to address shortages, countries can put in place policies to increase supply and to optimise usage. 
Za reševanje težav s pomanjkanjem lahko države vzpostavijo politike za povečanje dobave in optimizacijo uporabe.
The ways in which EU Member States have implemented the principle of VUD are difficult to assess in a comprehensive manner. 
Načine, kako države članice EU izvajajo načelo PBD, je težko celovito oceniti.
Reimbursement of travel costs can cover the actual costs or be a standard lump sum. 
Povračilo potnih stroškov lahko krije dejanske stroške ali pa je izplačano v obliki standardnega pavšalnega zneska.
Almost all countries report that a donor identification system was implemented in their country, in the majority of countries at national level. 
Skoraj vse države poročajo, da je bil v njihovi državi vzpostavljen sistem identifikacije darovalcev, v večini držav na nacionalni ravni.
A verification of the completeness of transposition into national legislation of the EU blood legislation, carried out by the Commission, demonstrated that it is fully transposed in all but one Member State. 
Preverjanje popolnosti prenosa zakonodaje EU o krvi v nacionalno zakonodajo, ki ga je izvedla Komisija, je pokazalo, da je v celoti prenesena v vseh državah članicah, razen v eni.
There appears to be a good interconnectivity with other health-related vigilance systems, in particular on medical devices and communicable diseases. 
Videti je, da obstaja dobra medsebojna povezanost z drugimi sistemi vigilance v zvezi z zdravjem, zlasti glede medicinskih pripomočkov in nalezljivih bolezni.
Accreditation, designation, authorisation or licensing of blood establishments. 
Akreditacija, imenovanje, odobritev ali izdajanje dovoljenj transfuzijskim ustanovam.
Other challenges to the principle of (self-) sufficiency are outlined below. 
Spodaj so prikazane še druge težave v zvezi z načelom (samo)zadostnosti.
Wherever different oversight activities (authorisation, inspection, haemovigilance) are undertaken by different authorities, good communication and coordination between respective authorities needs to be ensured. 
Kadar različne nadzorne dejavnosti (odobritev, inšpekcija, hemovigilanca) izvajajo različni organi, je treba zagotoviti dobro komunikacijo in usklajevanje med zadevnimi organi.
Since 2003, a number of projects have been funded under the multi-annual programmes for Union action in the field of health addressing the area of blood and blood components. 
Od leta 2003 je bilo financiranih več projektov v okviru večletnih programov za ukrepanje Unije na področju zdravja, ki so se nanašali na kri in komponente krvi.
The debate on possible compensation and incentives for donors plays an important role in supply management (see below). 
Razprava o morebitnem nadomestilu in spodbudah za darovalce ima pomembno vlogo pri upravljanju dobave (glej spodaj).
The VUD survey addressed questions on the balance between supply and demand, and the measures taken to achieve sufficiency. 
Anketa o PBD se je nanašala na vprašanja ravnotežja med ponudbo in povpraševanjem ter ukrepe, sprejete za zagotovitev zadostnosti.